ENSYSCE BIOSCIENCES, INC. Other Non-Current Liabilities
ENSYSCE BIOSCIENCES, INC. (ENSC) had Other Non-Current Liabilities of $35 as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-03-30
- 2025-09-30: Other Liabilities, Noncurrent $35.00.
- 2025-06-30: Other Liabilities, Noncurrent $1.03K.
- 2025-03-31: Other Liabilities, Noncurrent $130.18K.
- 2024-12-31: Other Liabilities, Noncurrent $10.10K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2025-09-30 | $35.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.03K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $130.18K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $10.10K 10-K · filed 2026-03-30 |
| 2023-12-31 | $26.39K 10-K · filed 2025-03-10 |
| 2022-12-31 | $310.35K 10-K · filed 2024-03-15 |
| 2022-09-30 | $1.41M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $360.80K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $871.41K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.65M 10-K · filed 2023-03-30 |
| 2021-09-30 | $957.10K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |